# Hypoxia-induced production of the cyclolipodepsipeptide BE-43547 by Micromonospora sp. RV43

**Authors:** Marie Selch Tvilum, Camilla Bak Nielsen, Iben Steensgaard, Thomas Bjørnskov Poulsen, Mogens Johannsen, Thomas Tørring

PMC · DOI: 10.1099/mic.0.001662 · Microbiology · 2026-02-18

## TL;DR

This study shows that low-oxygen conditions trigger the production of BE-43547, an antibiotic effective against anaerobic Gram-positive bacteria.

## Contribution

The paper introduces a strategy linking compound function and regulation cues to discover new antibiotics.

## Key findings

- BE-43547 is selectively active against anaerobic Gram-positive bacteria.
- Micromonospora sp. RV43 produces BE-43547 under low-oxygen conditions.
- Linking function and regulation cues can aid in antibiotic discovery.

## Abstract

The urgent need for new antibiotics emphasizes the importance of investigating the many biosynthetic gene clusters that remain silent under standard culture conditions and of assigning functions to the many natural products already discovered. Conventional approaches, such as altering the screening medium composition or culture conditions to trigger production, are often labourious and disconnected from the function of the natural products. In this study, we combine antimicrobial assays and the controlled culture conditions available in benchtop bioreactors to demonstrate that BE-43547, a natural product that exists as a mixture of congeners, is selectively active against Gram-positive bacteria growing anaerobically. Furthermore, we show that the producing organism Micromonospora sp. RV43 activates the biosynthesis of BE-43547 when cultured under low-oxygen conditions. These findings illustrate that linking compound function and regulation cues can provide a powerful strategy for discovering antibiotics with a new mode of action.

## Linked entities

- **Species:** Micromonospora sp. RV43 (taxon 1661387)

## Full-text entities

- **Diseases:** DSM 30054 (MESH:D001714), MBC (MESH:D010585), infectious diseases (MESH:D003141), Clostridium difficile (MESH:D003015), cytotoxicity (MESH:D064420), infections (MESH:D007239), PC (MESH:D054218), hypoxic (MESH:D002534), Hypoxia (MESH:D000860), APD-CLD (MESH:D053632), cancer (MESH:D009369)
- **Chemicals:** N,N-dimethylformamide (MESH:D004126), GMP (MESH:C066524), thioglycolate (MESH:D013864), AMP (MESH:D000249), H2SO4 (MESH:C033158), pO2 (MESH:C093415), DMSO (MESH:D004121), glucose (MESH:D005947), Rakicidin D (MESH:C000723972), guanosine (MESH:D006151), cytidine (MESH:D003562), Mitomycin C (MESH:D016685), Mycothiol (MESH:C089265), ethyl acetate (MESH:C007650), OSMAC (-), N-acetylglucosamine (MESH:D000117), arginine (MESH:D001120), starch (MESH:D013213), phenylalanine (MESH:D010649), amino acid (MESH:D000596), thiol (MESH:D013438), 2-aminoadipic acid (MESH:D015074), iron (MESH:D007501), vancomycin (MESH:D014640), water (MESH:D014867), NaOH (MESH:D012972), glutamate (MESH:D018698), citrulline (MESH:D002956), ACN (MESH:C084683), ergothioneine (MESH:D004880), Oxygen (MESH:D010100), uridine (MESH:D014529), formic acid (MESH:C030544), NaCl (MESH:D012965), methanol (MESH:D000432), BE- (MESH:D001608), adenosine (MESH:D000241), metal (MESH:D008670), metronidazole (MESH:D008795), carbon (MESH:D002244), agar (MESH:D000362), casamino acids (MESH:C017721), acetonitrile (MESH:C032159), nitrogen (MESH:D009584), CMP (MESH:D003568)
- **Species:** Acinetobacter baumannii (species) [taxon 470], Micromonospora eburnea (species) [taxon 227316], Micromonospora sp. (species) [taxon 1876], Enterococcus faecium (species) [taxon 1352], Klebsiella oxytoca (species) [taxon 571], Micromonospora chalcea (species) [taxon 1874], Streptomyces sp. CNQ-525 (species) [taxon 418855], Homo sapiens (human, species) [taxon 9606], Clostridioides difficile (species) [taxon 1496], Enterobacter cloacae (species) [taxon 550], Mycobacterium tuberculosis (species) [taxon 1773], Staphylococcus aureus (species) [taxon 1280], Aplysina aerophoba (species) [taxon 289389], Micromonospora sp. RV43 (species) [taxon 1661387], Streptomyces coelicolor (species) [taxon 1902], Actinomycetota (actinobacteria, phylum) [taxon 201174], aureus [taxon 46170], Peptostreptococcus anaerobius (species) [taxon 1261], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Klebsiella pneumoniae (species) [taxon 573], Pseudomonas aeruginosa (species) [taxon 287], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** DSM 20231 — Homo sapiens (Human), Transformed cell line (CVCL_AY38), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916061/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12916061/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC12916061/full.md

---
Source: https://tomesphere.com/paper/PMC12916061